CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Juno Therapeutics, Inc.  (JUNO)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
 

JUNO's Revenue Year on Year Growth by Quarter and Year

Juno Therapeutics,'s Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
JUNO Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 21.15 4.15 0.00
III Quarter September - 20.83 1.60 0.00
II Quarter June - 27.60 12.46 0.00
I Quarter March 19.33 9.78 - 0.00
FY   19.33 79.36 18.21 -

Financial Statements
Juno Therapeutics,'s first quarter 2017 Revenue $ 19.33 millions JUNO's Income Statement
Juno Therapeutics,'s first quarter 2016 Revenue $ 9.78 millions Quarterly JUNO's Income Statement
JUNO's Growth by Division See JUNO's Growth by Segment

JUNO Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - 409.64 % - -
III Quarter September - 1201.88 % - -
II Quarter June - 121.51 % - -
I Quarter March 97.62 % - - -
FY   - 335.8 % - -



JUNO Revenue Growth Comment
Juno Therapeutics, Inc. reported Revenue rise of 97.62% year on year in the first quarter, to $ 19.33 millions, this is lower than Juno Therapeutics, Inc.'s recent average Revenue surge of 457.17%.

Looking into first quarter results within Biotechnology & Drugs industry 13 other companies have achieved higher Revenue growth. While Juno Therapeutics, Inc.' s Revenue jump of 97.62% ranks overall at the positon no. 248 in the first quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #14
Healthcare Sector #55
S&P 500 #248
Revenue Y/Y Growth Statistics
High Average Low
1200 % 457.17 % 97.72 %
(Sep 30 2016)   (Mar 31 2017)

You need to upgrade your Flash Player

Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
JUNO's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for JUNO's Competitors
Revenue Growth for Juno Therapeutics,'s Suppliers
Revenue Growth for JUNO's Customers

You may also want to know
JUNO's Annual Growth Rates JUNO's Profitability Ratios JUNO's Asset Turnover Ratio JUNO's Dividend Growth
JUNO's Roe JUNO's Valuation Ratios JUNO's Financial Strength Ratios JUNO's Dividend Payout Ratio
JUNO's Roa JUNO's Inventory Turnover Ratio JUNO's Growth Rates JUNO's Dividend Comparisons



Companies with similar Revenue jump for the quarter ending Mar 31 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2017
Novocure Ltd  167.22 %$ 167.218 millions
Invitae Corp  161.39 %$ 161.391 millions
Eagle Pharmaceuticals, Inc.  159.51 %$ 159.515 millions
Alnylam Pharmaceuticals, Inc.  158.13 %$ 158.135 millions
Catasys, Inc.  150.27 %$ 150.275 millions
Catalyst Biosciences, Inc.  148.62 %$ 148.624 millions
Viveve Medical, Inc.  136.84 %$ 136.838 millions
Flex Pharma, Inc.  134.72 %$ 134.724 millions
China Longyi Group International Holdings Ltd  126.39 %$ 126.388 millions
Neos Therapeutics, Inc.  117.85 %$ 117.847 millions
Hemispherx Biopharma Inc  115.38 %$ 115.385 millions
Novabay Pharmaceuticals, Inc.  115.30 %$ 115.300 millions
Aveo Pharmaceuticals Inc  110.47 %$ 110.474 millions
Egalet Corp  103.79 %$ 103.793 millions
Delcath Systems, Inc.  100.81 %$ 100.811 millions
Green Meadow Products, Inc.  100.00 %$ 100.000 millions
Uluru Inc.  99.57 %$ 99.571 millions
Juno Therapeutics, Inc.  97.72 %$ 97.719 millions
Biocryst Pharmaceuticals Inc  95.79 %$ 95.788 millions
Kite Pharma, Inc.  91.85 %$ 91.847 millions
Neurometrix, Inc.  89.26 %$ 89.260 millions
Eleven Biotherapeutics, Inc.  85.59 %$ 85.590 millions
Nantkwest, Inc.  83.33 %$ 83.333 millions
Psivida Corp.  82.10 %$ 82.099 millions
Cempra, Inc.  81.86 %$ 81.859 millions
Vertex Pharmaceuticals Inc  79.54 %$ 79.541 millions
Ani Pharmaceuticals Inc  78.20 %$ 78.195 millions
Vivus Inc  76.27 %$ 76.273 millions
Anavex Life Sciences Corp.  73.19 %$ 73.195 millions
Keryx Biopharmaceuticals Inc  73.17 %$ 73.172 millions


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com